Today's Low
₹ 860.55
Today's High
₹ 878.80
52 Weeks Low
₹ 546.75
52 Weeks High
₹ 1,224.20
Lower
₹ 690.50
Upper
₹ 1,035.70
Anupam Rasayan India Ltd. engages in the custom synthesis and manufacturing of specialty chemicals in India. The company offers life science related specialty chemicals, such as agro intermediates and agro active ingredients for the agrochemicals industry; anti-bacterial and ultra violet protection intermediates and ingredients for the personal care industry; and intermediates and key starting materials for active pharmaceutical ingredients. It also provides other specialty chemicals used in various end-user segments, comprising specialty pigments, specialty dyes, and polymer additives. It also exports its products. Anupam Rasayan India Ltd. was founded in 1984 and is based in Surat, India.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Total Current Assets | 2,111.2 | 1,446.6 | 1,099.5 | 557.5 | 424.6 | 337.9 | 225.8 | 152.2 |
Total Non-Current Assets | 1,666.7 | 1,443.9 | 1,207.1 | 1,112.5 | 899.0 | 663.3 | 406.4 | 328.9 |
Total Assets | 3,777.9 | 2,890.6 | 2,306.5 | 1,670.0 | 1,323.6 | 1,001.2 | 632.2 | 481.2 |
Total Current Liabilities | 810.8 | 595.1 | 429.1 | 499.7 | 340.5 | 265.6 | 151.1 | 162.7 |
Total Non-Current Liabilities | 459.1 | 568.6 | 304.0 | 576.8 | 476.0 | 278.4 | 231.5 | 171.2 |
Shareholder's Funds | 2,372.6 | 1,726.9 | 1,573.4 | 593.5 | 507.1 | 457.2 | 249.7 | 147.3 |
Total Liabilities | 3,777.9 | 2,890.6 | 2,306.5 | 1,670.0 | 1,323.6 | 1,001.2 | 632.2 | 481.2 |
The Industry Quick Ratio stands at 1.32, vs the Quick Ratio of 0.52, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.85, vs the Debt to Equity Ratio of 1.38, which results in a Negative aspect.
The Industry Current Ratio stands at 1.93, vs the Current Ratio of 1.12, which results in a Negative aspect.
The Industry Price to BV stands at 11.04, vs the Price to BV of 3.27, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Total Income | 1,601.9 | 1,073.8 | 810.9 | 528.9 | 501.5 | 342.8 | 288.3 | 287.8 |
Total Expenditure | 1,196.1 | 769.0 | 617.3 | 399.8 | 408.4 | 267.9 | 218.0 | 208.2 |
Operating Profit(Excl OI) | 439.9 | 312.2 | 220.2 | 145.6 | 112.6 | 81.3 | 81.2 | 87.5 |
Add: Other Income | 34.2 | 7.3 | 26.6 | 16.6 | 19.5 | 6.4 | 10.9 | 7.9 |
Operating Profit | 439.9 | 312.2 | 220.2 | 145.6 | 112.6 | 81.3 | 81.2 | 87.5 |
Less: Interest | 62.7 | 30.8 | 68.5 | 45.3 | 24.4 | 14.6 | 21.1 | 21.3 |
PBDT | 377.3 | 281.3 | 151.7 | 100.4 | 88.3 | 66.7 | 60.1 | 66.2 |
Less: Depreciation Amortization | 71.1 | 60.1 | 51.7 | 28.7 | 22.5 | 17.6 | 15.4 | 12.6 |
PBT & Exceptional Items | 306.2 | 221.2 | 100.0 | 71.7 | 65.7 | 49.2 | 44.7 | 53.7 |
Less: Exceptional Income Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 307.7 | 221.9 | 100.0 | 71.7 | 65.7 | 49.2 | 44.7 | 53.7 |
Less: Taxation | 90.8 | 69.7 | 29.7 | 18.5 | 15.5 | 9.3 | 10.0 | 11.0 |
Profit After Tax | 216.9 | 152.2 | 70.3 | 53.2 | 50.2 | 39.9 | 34.8 | 42.7 |
Earnings Per Share | 1.7 | 1.5 | 0.7 | 1.1 | 1.0 | 0.0 | 0.0 | 0.0 |
The Industry PAT Growth stands at 39.68, vs the PAT Growth of 5.97, which results in a Negative aspect.
The Industry Dividend Yield stands at 0.48, vs the Dividend Yield of 0.29, which results in a Negative aspect.
The Industry PE Ratio stands at 59.63, vs the PE Ratio of 63.99, which results in a Positive aspect.
The Industry PAT Margin stands at 13.16, vs the PAT Margin of 10.06, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
---|---|---|---|---|---|---|---|---|
Profit Before Tax | 307.7 | 221.2 | 100.0 | 71.7 | 65.7 | 49.2 | 44.7 | 53.7 |
Tax Paid | -69.3 | -35.8 | -17.6 | -9.2 | -12.5 | -8.5 | 0.0 | 0.0 |
Adjustment | 149.3 | 84.9 | 119.7 | 80.9 | 43.8 | 32.1 | 36.5 | 33.8 |
Changes In Working Capital | 307.7 | 221.2 | 100.0 | 71.7 | 65.7 | 49.2 | 44.7 | 53.7 |
Cash Flow after changes in Working Capital | 361.3 | -135.5 | 19.0 | 104.2 | 51.4 | -13.5 | 17.1 | 68.8 |
Cash Flow from Operating Activities | 292.1 | -171.2 | 1.5 | 94.9 | 38.9 | -21.9 | 17.1 | 68.8 |
Cash Flow from Investing Activities | -522.7 | -412.0 | -193.1 | -178.2 | -250.2 | -255.1 | -93.1 | -168.5 |
Cash Flow from Financing Activities | 370.6 | 384.4 | 415.8 | 101.9 | 205.7 | 276.5 | 73.0 | 114.8 |
Net Cash Inflow / Outflow | 140.1 | -198.9 | 224.1 | 18.6 | -5.6 | -0.5 | -3.1 | 15.1 |
Opening Cash & Cash Equivalents | 47.8 | 241.2 | 17.0 | -1.6 | 7.4 | 7.9 | 15.1 | 0.0 |
Closing Cash & Cash Equivalent | 187.8 | 42.3 | 241.2 | 17.0 | 1.8 | 7.4 | 12.0 | 15.1 |
The Industry PCF RATIO stands at 48.85, vs the PCF RATIO of 0.00, which results in a Negative aspect.
The Industry PFCF Ratio stands at 6.27, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 2,955.2 | 3,921.5 | 3,863.9 | 4,799.6 | 3,827.5 | 3,862.4 | 3,065.6 | 3,172.4 | 2,661.6 | 2,489.2 | 2,336.8 | 2,716.7 |
Total Income | 2,979.0 | 3,956.1 | 3,987.6 | 5,042.3 | 3,887.9 | 3,831.5 | 2,971.5 | 3,168.6 | 2,711.2 | 2,551.6 | 2,379.7 | 2,741.6 |
Total Expenditure | 2,164.4 | 2,846.7 | 2,849.8 | 3,626.7 | 2,808.1 | 2,819.9 | 2,126.9 | 2,199.4 | 1,910.8 | 1,849.3 | 1,730.2 | 2,086.6 |
PBIDT (Excl OI) | 790.8 | 1,074.8 | 1,014.1 | 1,172.9 | 1,019.4 | 1,042.5 | 938.7 | 973.0 | 750.8 | 639.9 | 606.7 | 630.0 |
Other Income | 23.8 | 34.6 | 123.7 | 242.6 | 60.4 | -30.9 | -94.1 | -3.8 | 49.6 | 62.4 | 42.9 | 24.9 |
Operating Profit | 814.6 | 1,109.4 | 1,137.9 | 1,415.6 | 1,079.8 | 1,011.5 | 844.6 | 969.2 | 800.4 | 702.3 | 649.5 | 655.0 |
Interest | 251.3 | 204.3 | 178.1 | 202.6 | 141.6 | 160.2 | 121.6 | 137.7 | 52.3 | 52.2 | 66.1 | 189.9 |
Exceptional Items | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 563.3 | 905.1 | 959.8 | 1,213.0 | 938.2 | 851.4 | 723.0 | 831.5 | 748.1 | 650.2 | 583.4 | 465.1 |
Depreciation | 204.3 | 198.5 | 186.8 | 185.3 | 184.8 | 177.2 | 157.1 | 154.3 | 155.0 | 148.2 | 143.8 | 133.4 |
Profit Before Tax | 359.0 | 706.7 | 773.0 | 1,027.7 | 753.3 | 674.2 | 565.9 | 677.2 | 593.2 | 502.0 | 439.7 | 331.8 |
Tax | 98.8 | 219.7 | 250.5 | 301.3 | 209.2 | 196.1 | 191.5 | 223.3 | 213.9 | 141.1 | 118.4 | 110.3 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 260.2 | 486.9 | 522.5 | 726.4 | 544.1 | 478.1 | 374.4 | 453.9 | 379.2 | 360.9 | 321.2 | 221.4 |
Net Profit | 260.2 | 486.9 | 522.5 | 726.4 | 544.1 | 478.1 | 374.4 | 453.9 | 379.2 | 360.9 | 321.2 | 221.4 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 1,095.2 | 1,076.1 | 1,075.4 | 1,074.7 | 1,072.1 | 1,002.9 | 1,002.5 | 1,002.5 | 999.2 | 999.2 | 999.2 | 999.2 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 1.7 | 3.8 | 4.9 | 7.0 | 5.3 | 4.8 | 4.0 | 4.6 | 3.8 | 3.6 | 3.2 | 2.7 |
Operating Profit Margin | 27.6 | 28.3 | 29.4 | 29.5 | 28.2 | 26.2 | 27.6 | 30.6 | 30.1 | 28.2 | 27.8 | 24.1 |
Net Profit Margin | 8.8 | 12.4 | 13.5 | 15.1 | 14.2 | 12.4 | 12.2 | 14.3 | 14.2 | 14.5 | 13.7 | 8.2 |
The Industry Net Sales Growth stands at 22.68, vs the Net Sales Growth of 5.46, which results in a Negative aspect.
The Industry Mcap Growth stands at 41.03, vs the Mcap Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 906.95 | 924.81 | 880.49 |
R3 | 897.57 | 897.83 | 875.47 |
R2 | 888.18 | 888.31 | 873.80 |
R1 | 879.32 | 879.58 | 872.12 |
Pivot | 869.93 | 870.06 | 869.93 |
S1 | 861.07 | 861.33 | 868.78 |
S2 | 851.68 | 851.81 | 867.10 |
S3 | 842.82 | 843.08 | 865.43 |
S4 | 833.95 | 815.31 | 860.41 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
11.56
Bullish
RSI
35.94
Neutral
ROC
-8.98
Bearish
UltimateOscillator
37.07
Neutral
Williams Indicator
-82.37
Bullish
CCI Indicator
-105.38
Bullish
MACD
-2,281.47
Bearish
Stochastic Indicator
15.52
Bullish
ATR
26.14
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|---|---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|---|---|---|
20-11-2023 | 0.50 | 5 | Interim |
15-05-2023 | 1.50 | 15 | Interim |
08-02-2023 | 0.60 | 6 | Interim |
02-09-2022 | 1.00 | 10 | Final |
03-08-2022 | 0.40 | 4 | Interim |
17-11-2021 | 0.50 | 5 | Interim |
15-09-2021 | 0.50 | 5 | Final |
Date Of Conduct | Board Meeting Details |
---|---|
12-02-2024 | Quarterly Results |
07-11-2023 | Interim Dividend & Preferential Issue of shares & Issue Of Warrants & Quarterly Results |
01-08-2023 | Quarterly Results |
03-05-2023 | Third Interim Dividend & Audited Results |
27-01-2023 | Second Interim Dividend & Quarterly Results |
27-10-2022 | Quarterly Results |
03-10-2022 | Inter alia, to consider and determine the issue price of Equity Shares to be issued under the QIP, including any discount on the floor price calculated in accordance with the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the ?SEBI ICDR Regulations?) |
25-07-2022 | Quarterly Results & First Interim Dividend |
24-05-2022 | Preferential Issue of shares Inter alia, to discuss and consider, among other things, raising of funds either through issuance of equity shares, and or bonds including foreign currency convertible bonds I debentures/ non-convertible debt instruments along with warrants/ convertible debentures/ securities and/ or any other equity based instruments/ securities by way of qualified institutions placement or rights issue or preferential allotment, or through any other permissible mode or any combination thereof of any of the above, in accordance with the relevant provisions of applicable law and subject to approval of the Company's shareholders and receipt of applicable regulatory approvals |
12-05-2022 | Final Dividend & Audited Results |
11-02-2022 | Quarterly Results |
10-11-2021 | Quarterly Results (Revised) & First Interim Dividend |
06-08-2021 | Quarterly Results |
12-06-2021 | Final Dividend & Audited Results & Quarterly Results |